Evaluation of a Chitosan Nano-Hybrid Material Containing Silanol Group and Calcium Salt as a Bioactive Bone Graft

Abstract:

A bioactive chitosan-siloxane nano-hybrid material was newly developed and evaluated for the potential application as a bone graft material. The chitosan which can be dissolved in organic solvent was synthesized by the reaction with phtalic anhydride (Ph-Chitosan) and it was then reacted with 3-isocyanatopropyl triethoxysilane (Si-Chitosan) in dimethylformamide. Following this, the Si-Chitosan was hydrolyzed and condensed to yield a hybrid sol-gel material (Si-O-Chitosan). The gelation was carried out for 1 week at ambient condition in a covered Teflon mold with a few pinholes and then dried under vacuum at room temperature for 48 h. The bioactivity of the chitosan nano-hybrid material was evaluated by examining the apatite forming ability in the simulated body fluid (SBF). The surface microstructure and functional groups of the specimen was analyzed by field emission scanning electron microscopy and Fourier transformed infrared spectroscopy, respectively. The crystal phases of the specimen before and after the bioactivity testing were analyzed by thin film X-ray diffractometry. Newly developed chitosan nano-hybrid material showed apatite-forming ability in the SBF within 1 week soaking and this ability was believed to come from the silanol group formed on the surface of Si-O-Chitosan and calcium salt which increased the ionic activity product of apatite in the SBF.

• Periodical: Key Engineering Materials (Volumes 284-286)
• Pages: 765-768
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.284-286.765
• Online since: April 2005
• Authors: Sang Hoon Rhee, Yong Keun Lee, Bum Soon Lim
• Keywords: Bioactivity, Chitosan (CS), Hybrid, Siloxane Linkage, Simulated Body Fluid (SBF)

References

[1] Rhee S. H., Choi J. Y., Kim H. M.: Biomaterials 23 (2002), p.4915.

[2] Rhee S. H.: Biomaterials 24 (2003), p.1721.

[3] Rhee S. H.: J. Biomed. Mater. Res. 67A (2003), p.1131.

[4] Rhee S. H.: Biomaterials 25 (2004), p.1167.

[5] Yoo J. J., Rhee S. H.: J. Biomed. Mater. Res. 68A (2004), p.401.

[6] Rhee S. H., Choi J. Y.: J. Am. Ceram. Soc. 85 (2002), p.1318.

[7] Rhee S. H., Hwang M. H., Si H. J., Choi J. Y.: Biomaterials 24 (2003), p.901.

[8] Tsuru K., Ohtsuki C., Osaka A., Iwamoto T., Mackenzie J. D.: J. Mater. Sci. Mater. Med. 8 (1997), p.157.

[9] Chen Q., Miyaji F., Kokubo T., Nakamura T.: Biomaterials 20 (1999), p.1127.

[10] Chen Q., Miyata N., Kokubo T., Nakamura T.: J. Biomed Mater. Res. 51 (2000), p.605.

[11] Chen Q., Miyata N., Kokubo T., Nakamura T.: J. Mater. Sci.: Mater. Med. 12 (2002), p.515.

[12] Miyata N., Fuke K., Chen Q., Kawashita M., Kokubo T., Nakamura T.: Biomaterials 23 (2002), p.3033.

[13] Kamitakahara M., Kawashita M., Miyata N., Kokubo T., Nakamura T.: Biomaterials 24 (2003), p.1357.

[14] Miyata N., Fuke K., Chen Q., Kawashita M., Kokubo T., Nakamura T.: Biomaterials 25 (2004), p.1.

[15] Rhee S. H., Lee Y. K., Lim B. S., Yoo J. J., Kim H. J.: Biomacromolecules 5 (2004), p.1575.

[16] Kokubo T., Kushitani H., Sakka S., Kitsugi T., Yamamuro T.: J Biomed Mate Res 24 (1990), p.721.

DOI: 10.1002/jbm.820240607

[17] Vandel V. P. J., Matthew H. W. T., Desilva S. P., Mayton L., Wu B., Wooley P. H.: J Biomed Mater Res 59 (2002), p.585.

[18] Lee J. Y., Nam S. H., Im S. Y., Park Y. J., Lee Y. M., Seol Y. J., Chung J. P., Lee S. J.: J Controll Rel 78 (2002), p.187.

[19] Eugene K., Lee Y. L.: Biomaterials 24 (2003), p.2339.